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Table. Effect of preoperative cardiac stress testing (CST) on outcomes
after open or endovascular abdominal aortic aneurysm repair
Outcomes (CST vs no CST) OR (95% CI) P
30-day
Myocardial infarction 1.16 (0.71-1.92) .55
MACE 1.15 (0.89-1.49) .28
Mortality 0.70 (0.44-1.10) .12
MACE or mortality 1.03 (0.82-1.29) .82
1-year mortality 0.99 (0.69-1.41) .95
CI, Conﬁdence interval; MACE, major adverse cardiac event; OR, odds
ratio.
Fig. Preoperative computed tomographic angiography demonstrating two
large proximal right renal artery aneurysms (A-B). Angiography following
placement of initial covered stent in proximal-mid right renal artery (C). Given
persistent ﬁlling of the more proximal aneurysm, a brachial approach was used
to place a second, more proximal covered stent (D). Postoperative imaging
demonstrating successful aneurysm exclusion and absence of endoleak at two-
week (E-F), one-year (G), and two-year (H) follow-up periods.
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Objective: Cardiac stress testing (CST) is commonly used to help
determine whether patients with abdominal aortic aneurysms (AAAs) are
candidates for open (oAAA) vs endovascular repair (EVAR), although it is
unknown whether CST achieves its goal of optimizing patient selection
and postoperative outcomes. This study examined whether use of CST im-
proves adverse cardiac events and survival after AAA repair.
Methods: We identiﬁed 3635 patients in the Vascular Quality Initia-
tive (VQI) database (2010-2012) with an AAA $5.0 cm who were candi-
dates for oAAA or EVAR. The VSG Cardiac Risk Index was used to stratify
patient risk. We then applied generalized estimating equations with inverse
probability weighting to adjust for patient factors and hospital level CSTutilization to evaluate the effect of CST on 30-day major adverse cardiac
events and mortality after AAA repair. Analyses were restricted to hospitals
with 20% to 80% CST utilization to facilitate adjustment of the utilization
rate.
Results: CST was used in 1627 patients (45%) during AAA workup,
including 451 of 794 patients (57%) selected for oAAA and 1176 of
2841 patients (41%) selected for EVAR. After inverse probability weighting,
the use of CST was not associated with the proportion of patients receiving
oAAA vs EVAR (odds ratio, 1.00; 95% conﬁdence interval, 0.77-1.32).
Compared with patients without CST during the AAA workup, adjusted an-
alyses revealed that CST utilization was not associated with improved out-
comes after AAA repair (Table). Among patients receiving CST, an
abnormal CST was not signiﬁcantly associated with selection of oAAA vs
EVAR or with postoperative outcomes after adjustment for the VSG cardiac
risk score.
Conclusions: Utilization of CST during workup for AAA repair is not
associated with improved postoperative outcomes. Our results suggest that
CST adds no value beyond known clinical risk factors when selecting pa-
tients for oAAA vs EVAR or in predicting postoperative cardiac events.Author Disclosures: B. S. Brooke: None; Y. Zhang: None; T. H.
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Objective: Fenestrated endovascular aortic stent grafts (FEVAR) are
high radiation dose cases, yet no skin injuries were found retrospectively
in our 61 cases with a mean peak skin dose (PSD) of 6.8 Gy. We hypothe-
size that skin injury is under-reported. This study examined the determin-
istic effects in FEVARs after procedural changes implemented to detect
skin injury.
Methods: All procedures with a radiation dose >5 Gy reference air
kerma (RAK; NCRP threshold for substantial radiation dose level
[SRDL]) were included during a 6-month period. Patients were questioned
about skin erythema, epilation, and necrosis, with a physical examination of
the back completed daily until discharge and then at 2 weeks, 4 weeks, and
3 months. PSD distributions were calculated using custom software using
input data from ﬂuoroscopic machine logs and were validated against gaf-
chromic ﬁlm measurements using linear regression. Dose was summed for
the subset of patients with multiple procedures within 6 months of the
SRDL event, consistent with TJC recommendations.
Results: Twenty-two cases reached a RAK of 5 Gy. The average RAK
was 7.6 6 1.9 Gy (range, 5.1-11.4 Gy), and the mean PSD was 5.9 6 1.5
Gy (range, 4.0-8.9 Gy). Fifty-ﬁve percent had had multiple endovascular
procedures within 6 months of the SRDL event. The mean RAK for this
subset was 9.6 6 2.4 Gy (range, 5.5-13.4 Gy), and mean PSD was 6.2 6
2.0 Gy (range, 4.5-11.0 Gy). Gafchromic ﬁlm measurements were not
different from PSD estimations (P < .001), with a constant of proportion-
ality of 0.996 0.02. One patient died before the ﬁrst postoperative visit. No
radiation skin injuries were found. Putative risk factors for skin injury were
evaluated: Smoking (32%), diabetes (14%), cytotoxic drugs (9%), and fair
skin type (91%). No other risk factors were present (hyperthyroidism,
collagen vascular disorders).
Conclusions: Radiation doses in this study exceeded published
thresholds for cutaneous injury, yet no radiation skin injuries were observed.
This suggests that deterministic effects are likely less frequent than
